Insmed (INSM) Net Shares Issued and Repurchased (2010 - 2017)
Insmed (INSM) posted Net Shares Issued and Repurchased of $940060.0 for Q1 2017, down 62.88% on a QoQ basis from $2.5 million in Q4 2016, and down 4.9% year-over-year from $988500.0 in Q1 2016.
Analysis
Insmed (INSM) Net Shares Issued and Repurchased (2010 - 2017) Analysis & Trends
Insmed has reported Net Shares Issued and Repurchased for 8 years, with the latest figure at $940060.0 in Q1 2017.
- On a quarterly basis, Net Shares Issued and Repurchased fell 4.9% year-over-year to $940060.0 in Q1 2017; TTM through Mar 2017 was $940060.0, a 4.9% decrease from a year earlier, with the FY2016 full-year figure at $2.5 million, up 33.1% from the prior year.
- Net Shares Issued and Repurchased was $940060.0 for Q1 2017 at Insmed, down from $2.5 million in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $2.5 million in Q4 2016, with the low at -$150000.0 in Q3 2014.
- Average Net Shares Issued and Repurchased over 5 years is $1.2 million, with a median of $964280.0 recorded in 2016.
- The sharpest annual moves came in 2013 and 2014: Net Shares Issued and Repurchased soared 108.13% in 2013, then tumbled 31.12% in 2014.
- Over 5 years, Net Shares Issued and Repurchased stood at $2.3 million in 2013, then slumped by 31.12% to $1.6 million in 2014, then grew by 18.89% to $1.9 million in 2015, then surged by 33.1% to $2.5 million in 2016, then slumped by 62.88% to $940060.0 in 2017.
- The last three Net Shares Issued and Repurchased figures came in at $940060.0 (Q1 2017), $2.5 million (Q4 2016), and $988500.0 (Q1 2016), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 940,060.00 |
| Dec 31, 2016 | 2.53 Mn |
| Mar 31, 2016 | 988,500.00 |
| Dec 31, 2015 | 1.90 Mn |
| Mar 31, 2015 | 619,150.00 |
| Dec 31, 2014 | 1.60 Mn |
| Sep 30, 2014 | -150,000.00 |
| Mar 31, 2014 | 649,050.00 |
| Dec 31, 2013 | 2.32 Mn |
| Mar 31, 2013 | 552,250.00 |
| Dec 31, 2012 | 1.12 Mn |
| Dec 31, 2011 | 766,000.00 |
| Dec 31, 2010 | 45,000.00 |